SCHEMBL5075977

SCHEMBL5075977

C/C=C(/C(=O)O)c1ccccc1COc1cc(Cl)c(OCC)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 2/20 0.48
HPGD P15428 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ABL1 P00519 1/20 0.48
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
MAPT P10636 1/20 0.48
RIN1 Q13671 1/20 0.48
TP53 P04637 1/20 0.42
HTT P42858 1/20 0.42
MRGPRX4 Q96LA9 4/20 0.42
NPC1 O15118 3/20 0.40
NR4A2 P43354 2/20 0.40
KDM4E B2RXH2 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2D6 P10635 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5080507 0.91 TP53 (0.41) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL5080519 0.90 ALDH1A1 (0.40) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL5075974 0.90 RAB9A (0.46) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL5075979 0.90 RAB9A (0.46) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL6151247 0.90 HIF1A (0.44) RAB9AMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL5079483 0.89 MRGPRX4 (0.46) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL5074570 0.88 PTPN11 (0.42) RAB9AMEN1KMT2AALDH1A1LMNA
SCHEMBL5079564 0.88 PTPN11 (0.42) RAB9AMEN1KMT2AALDH1A1LMNA
SCHEMBL5076979 0.88 TP53 (0.40) RAB9AMEN1KMT2AALDH1A1HPGD
SCHEMBL5080373 0.88 HTT (0.40) RAB9AMEN1KMT2AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7435844-B2 Analogous compounds of strobilurines and their use as acaricides and insecticides ISAGRO RICERCA S.R.L. (IT) 2008-10-14 US disclosed
US-20060235075-A1 Analogous compounds of strobilurines and their use as acaricides and insecticides ISAGRO RICERCA S.R.L. (IT) 2006-10-19 US disclosed
EP-1494991-A1 ANALOGOUS COMPOUNDS OF STROBILURINES AND THEIR USE AS ACARICIDES AND INSECTICIDES Isagro Ricerca S.r.l. (IT) 2005-01-12 EP disclosed
WO-2003087032-A1 ANALOGOUS COMPOUNDS OF STROBILURINES AND THEIR USE AS ACARICIDES AND INSECTICIDES ISAGRO RICERCA S.R.L. (IT) 2003-10-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235075-A1 Analogous compounds of strobilurines and their use as acaricides and insecticides DDT, RYR1, TPMT RAB9A 1215/4885MEN1 2918/4885KMT2A 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.